Preference Study Between NovoFine® Autocover™ and a NovoFine® 8 mm Needle
Status and phase
Completed
Phase 4
Conditions
Diabetes
Healthcare Professionals
Delivery Systems
Treatments
Device: NovoFine® needle 8 mm
Device: autocover needle
Details and patient eligibility
About
This trial is conducted in Europe. The aim of this clinical trial is to assess the preference of 2 different needles used by nurses and health assistants. The trial consists of a handling test followed by a 12 week cross-over study.
Enrollment
78 patients
Sex
All
Volunteers
No Healthy Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:
- The participant must have been either a diabetes nurse or a diabetes health assistant with competence in subcutaneous injections of insulin for at least 4 weeks
- Participants must demonstrate proficiency with the injection device in the handling test prior to testing the NovoFine® Autocover™ Needle in patients
Trial design
Primary purpose
Treatment
Allocation
Randomized
Interventional model
Crossover Assignment
Masking
None (Open label)
Trial contacts and locations
1
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems